tiprankstipranks
Advertisement
Advertisement

EDIT Stock Latest News

Editas Medicine Shareholders Back Board, Pay and Auditor
Company AnnouncementsEditas Medicine Shareholders Back Board, Pay and Auditor
2d ago
8K
EDIT
Private Markets: Bezos’ Prometheus raises $12B as OpenAI files for IPO
PremiumThe Fly
Private Markets: Bezos’ Prometheus raises $12B as OpenAI files for IPO
9d ago
GS
TP
Editas Medicine preclinical data ‘looks highly supportive,’ says Evercore ISI
PremiumThe Fly
Editas Medicine preclinical data ‘looks highly supportive,’ says Evercore ISI
24d ago
EDIT
TD Cowen remains bullish on Editas Medicine after ‘compelling preclinical data’
PremiumThe Fly
TD Cowen remains bullish on Editas Medicine after ‘compelling preclinical data’
24d ago
EDIT
Editas Medicine Raises Capital Through Public Equity Offering
PremiumCompany Announcements
Editas Medicine Raises Capital Through Public Equity Offering
25d ago
8K
EDIT
Editas Medicine 55.6M share Secondary priced at $2.25
PremiumThe FlyEditas Medicine 55.6M share Secondary priced at $2.25
25d ago
EDIT
Editas Medicine Suspends Existing At-The-Market Offering Prospectus
Premium
Company Announcements
Editas Medicine Suspends Existing At-The-Market Offering Prospectus
25d ago
8K
EDIT
Editas Medicine announces common stock, warrant offering, no amount given
Premium
The Fly
Editas Medicine announces common stock, warrant offering, no amount given
26d ago
EDIT
Editas Showcases Promising EDIT-401 Data for Hyperlipidemia
PremiumCompany Announcements
Editas Showcases Promising EDIT-401 Data for Hyperlipidemia
26d ago
8K
EDIT
Analyst Maintains Buy on Editas Medicine, Reiterates $5 Price Target on EDIT-401 Progress and Strong Cash Runway
PremiumRatings
Analyst Maintains Buy on Editas Medicine, Reiterates $5 Price Target on EDIT-401 Progress and Strong Cash Runway
26d ago
EDIT
Editas Medicine presented preclinical data for EDIT-401 at EAS Congress
PremiumThe Fly
Editas Medicine presented preclinical data for EDIT-401 at EAS Congress
26d ago
EDIT
Editas Showcases Promising EDIT-401 Hyperlipidemia Preclinical Data
PremiumCompany Announcements
Editas Showcases Promising EDIT-401 Hyperlipidemia Preclinical Data
1M ago
8K
EDIT
Editas Medicine’s EDIT-401 shows efficacy and safety in hyperlipidemia
PremiumThe FlyEditas Medicine’s EDIT-401 shows efficacy and safety in hyperlipidemia
1M ago
EDIT
FDA Commissioner Marty Makary resigns
Premium
The Fly
FDA Commissioner Marty Makary resigns
1M ago
AZN
BMY
Analyst Phil Nadeau Reiterates Buy on Editas Medicine, Citing Promising EDIT-401 Data, Strong Cash Runway, and Large Untapped HeFH Opportunity
Premium
Ratings
Analyst Phil Nadeau Reiterates Buy on Editas Medicine, Citing Promising EDIT-401 Data, Strong Cash Runway, and Large Untapped HeFH Opportunity
2M ago
EDIT
Editas Medicine reports Q1 EPS (26c), consensus (24c)
PremiumThe Fly
Editas Medicine reports Q1 EPS (26c), consensus (24c)
2M ago
EDIT
EDIT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
EDIT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
EDIT
Private Markets: Cursor in talks for $2B, Blue Energy secures $380M
PremiumThe Fly
Private Markets: Cursor in talks for $2B, Blue Energy secures $380M
2M ago
BA
BE
Editas Medicine price target raised to $15 from $13 at Evercore ISI
PremiumThe Fly
Editas Medicine price target raised to $15 from $13 at Evercore ISI
2M ago
EDIT
USPTO Ruling Impacts Editas Medicine CRISPR IP Position
PremiumCompany AnnouncementsUSPTO Ruling Impacts Editas Medicine CRISPR IP Position
3M ago
8K
EDIT
Editas Medicine announces USPTO reaffirms prior decision on CRISPR/Cas9 patents
Premium
The Fly
Editas Medicine announces USPTO reaffirms prior decision on CRISPR/Cas9 patents
3M ago
EDIT
Regulatory Disruptions at FDA Threaten Editas Medicine’s Gene-Editing Timelines and Commercial Prospects
Premium
Company Announcements
Regulatory Disruptions at FDA Threaten Editas Medicine’s Gene-Editing Timelines and Commercial Prospects
3M ago
EDIT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >